Hormonal contraception and risk of venous thromboembolism: national follow-up study

Lidegaard, O., Lokkegaard, E., Svendsen, A. L., Agger, C.·2009·BMJ
DOI 10.1136/bmj.b2890

Cited by (712)

Items 401–500 of 712

  1. Endovascular Thrombectomy and Lysis for Acute Renal Vein Thrombosis: Indications, Technical Aspects, Outcome, and Disease Etiology
    Rachel Low, Jeremy Crane, Fred Sackey, Martin Malina · 2022 · Journal of Endovascular Therapy
  2. Risiken oraler Kontrazeptiva
    Christoph Rudolf Meier · 2011 · Therapeutische Umschau
  3. Developments in contraception
    Edith Weisberg · 2013 · Expert Opinion on Pharmacotherapy
  4. Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study
    Mohamed Abd-Allah Rezk, Tarek Mohammad Sayyed, Hamid Ellakwa, Ahmed Mohammed Zahran, Awni Gamal · 2016 · Gynecological Endocrinology
  5. O emprego dos contraceptivos orais combinados na síndrome dos ovários policísticos
    José Maria Soares, Edmund Chada Baracat · 2010 · Revista Brasileira Ginecologia e Obstetrícia
  6. Critique of a Danish cohort study on hormonal contraception and VTE
    Øjvind Lidegaard · 2010 · Journal of Family Planning and Reproductive Health Care
  7. Hormonal Contraception: Systemic Estrogen and Progestin Preparations.
    Nisha Verma, Carrie A. Cwiak, Andrew M Kaunitz · 2021 · PubMed
  8. Body height and risk of venous thromboembolism in men vs women
    Carl Arne Løchen Arnesen, Kristian Hveem, Maiken Elvestad Gabrielsen, John‐Bjarne Hansen, Sigrid Kufaas Brækkan · 2025 · Journal of Thrombosis and Haemostasis
  9. Cardiovascular Safety of Hormonal Contraception: Method-Specific Risks and Clinical Implications
    Iga Waluszewska, Antoni Borowiec, Alicja Paciorek, Letycja Musz, Wioletta Szczurek · 2026 · Medical Sciences
  10. Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance
    Laure Morimont, Nathalie Donis, Céline Bouvy, François Mullier, Jean‐Michel Dogné, Jonathan Douxfils · 2022 · Seminars in Thrombosis and Hemostasis
  11. V/P scan in diagnosis and follow-up of pulmonary embolism in 15-25-year-old females in relation to hormonal contraception use
    Daniela Chroustová, Jozef Kubinyi, Pavel Jansa, Lenka Vepřeková, Jiří Trnka · 2011 · Nuclear Medicine Review
  12. Expert opinion on a flexible extended regimen of drospirenone/ethinyl estradiol contraceptive
    Leo L. Han, Jeffrey T. Jensen · 2014 · Expert Opinion on Pharmacotherapy
  13. Hormonal anticonception anno 2013: a clinician's view.
    Marc A. Dhont, V. Verhaeghe · 2013 · Europe PMC (PubMed Central)
  14. Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy
    Fernie J. A. Penning‐van Beest, Irene D. Bezemer, Elisabeth Smits, Luis Alberto García Rodríguez, Lucía Cea Soriano, Francesco Lapi, Monica Simonetti, Alex Asiimwe, Ron M. C. Herings · 2020 · Contraception
  15. Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users
    Albe C. Swanepoel, Janette Bester, Zelda de Lange · 2020 · Microscopy and Microanalysis
  16. Combined oral contraceptives: Why, when, where?
    Athanasios Antoniou-Tsigkos, Konstantina Pastroma, Eleni Memi, Nikolaos Vrachnis, George P. Mastorakos · 2021 · Elsevier eBooks
  17. Estrogen‐based hormonal therapy and the risk of thrombosis in COVID ‐19 patients
    Corinne Marie Lavasseur, Rick Mathews, Jenny S. H. Wang, Kylee L. Martens, Hannah Stowe McMurry, Shira Peress, Jean M.G. Sabile, Thomas Kartika, Ileisa Oleson, Jamie Oi-Ting Lo et al. · 2023 · European Journal Of Haematology
  18. Systemic exogenous progestins with or without estrogens are associated with decreased rates of venous procedures for varicose veins
    Paarth Jain, Adam M. Ostrovsky, Paul J DiMuzio, Luis H. Eraso, Michael J. Nooromid, Dawn Maria Salvatore, Babak Abai · 2025 · Journal of Vascular Surgery Venous and Lymphatic Disorders
  19. Venous Thrombosis could be Gender Specific, Women Beware!
    Swati Srivastava, Iti Garg, Lilly Ganju, Bhuvnesh Kumar · 2019 · Defence Science Journal
  20. Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology
    Ilias Nikolakopoulos, Soheila Nourabadi, Joanna B. Eldredge, Lalitha Anand, Meng Zhang, Michael Qiu, David Rosenberg, Alex C. Spyropoulos · 2020 · Journal of Thrombosis and Thrombolysis
  21. Observational Studies
    Harald Herkner, Christoph Male · 2016 · Springer eBooks
  22. Review article: Acute superior mesenteric vessel ischaemia: A review of clinical practice and biomarkers
    Raeed Deen, Zhi Kiat Sia · 2022 · Emergency Medicine Australasia
  23. Sex differences in guideline‐consistent diagnostic testing for acute pulmonary embolism among adult emergency department patients aged 18–49
    Angela F. Jarman, Bryn E. Mumma, Richard White, Emily A. Dooley, Nuen Tsang Yang, Sandra L. Taylor, Craig D. Newgard, Cynthia D. Morris, Jared Cloutier, Brandon C. Maughan · 2023 · Academic Emergency Medicine
  24. Progestogens in Contraception
    Johannes Bitzer · 2015 · Springer eBooks
  25. Combined oral contraceptive pill and venous thromboembolism
    Anne Szarewski · 2011 · Expert Review of Obstetrics & Gynecology
  26. Assessment of Some Coagulation Parameters among Clients on Hormonal Contraceptive in a Tertiary Health Facility in Sokoto, North Western, Nigeria
    Osaro Erhabor · 2014 · Journal of Hematology & Thromboembolic Diseases
  27. TREATMENT OF MENSTRUAL DISORDER, DEPRESSION AND SEXUAL DYSFUNCTION IN A 27-YEAR-OLD WOMAN WITH POLYCYSTIC OVARY SYNDROME BASED ON IRANIAN TRADITIONAL MEDICINE (CASE REPORT)
    Elham Akhtari, Roshanak Mokaberinejad, Haleh Tajadini · 2017
  28. A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills
    Soheila Aminimoghaddam · 2017 · Journal of Obstetrics Gynecology and Cancer Research
  29. Young FADOI and gender medicine: sex gender differences in cardiovascular disease
    Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi · 2018 · Italian Journal of Medicine
  30. Oral Contraceptives and Neutropenia: A Population-Based Cohort Study
    Yael Shalev Rosenthal, Gabriel Chodick, Adam Rosenthal, Varda Shalev, Hila Shalev Ram, Gideon Koren · 2019 · Clinical Drug Investigation
  31. Vascular disease
    BRYAN CORRIN, Andrew Gordon Nicholson · 2011 · Elsevier eBooks
  32. Hormonal Contraceptives: Communication for Risk Awareness and Informed Choice, or a Public Scare?
    Barbara J. Mintzes, Teresa Leonardo Alves · 2020 · Springer eBooks
  33. Acne Vulgaris
    Zekayі Kutlubay, Ayşegül Sevim Keçici, Burhan Engіn, Server Serdaroğlu, Yalçın Tüzün · 2017 · InTech eBooks
  34. The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium
    Rachel B. Rapkin, Mitchell David Creinin · 2011 · Expert Opinion on Pharmacotherapy
  35. Rutiner ved førstegangsforskrivning av p-piller
    Alina Desiree Sandø, Siv Gyda Aanes, Lars Slørdal, Olav Spigset · 2010 · Tidsskrift for Den norske legeforening
  36. Oral Contraceptives and the Risk of Venous Thromboembolism
    Susan Sara Jick · 2014 · Springer eBooks
  37. Contraceptive options for women with SLE
    Diana Mansour · 2013 · Journal of Family Planning and Reproductive Health Care
  38. Combined oral contraceptive use and serotonin 2A and 2C receptor brain architecture in healthy women
    Anna Kauffmann, Anjali Sankar, Vincent Beliveau, Claus Svarer, Brice Ozenne, Patrick M. Fisher, Vibe G. Frøkjær, Søren Vinther Larsen · 2025 · medRxiv
  39. Acute exposure to oscillatory shear stress impairs endothelial function in oral contraceptive pill users across pill phases
    Lindsay A. Lew, Raelisa Etwaroo, Justin Bureau, Kyra E. Pyke · 2025 · Journal of Applied Physiology
  40. Cross‐sectional and longitudinal metabolomics‐based profiles associated with oral contraceptive and progestin‐only pill use: A Finnish population‐based study
    Elena Toffol, Jari K. Haukka, Pekka Jousilahti, Lara Lehtoranta, Anni Joensuu, Timo Partonen, Iris Erlund, Oskari Heikinheimo · 2025 · Acta Obstetricia Et Gynecologica Scandinavica
  41. Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review
    Juliette Hugueny, Anna de Ricolfis, Nicolaï Johnson, Nathalie Chabbert‐Buffet, Sarra Cristofari · 2025 · Thrombosis Research
  42. Advances in drug-releasing vaginal rings
    Clare F. McCoy, Xinyu Zhao, Xin Shen, Yahya H. Dallal Bashi, Diarmaid J. Murphy, Peter Boyd, Karl R. Malcolm · 2025 · Journal of Drug Delivery Science and Technology
  43. Adenomyosis with abnormal uterine bleeding complicated by venous thrombosis: a case series and literature review
    Hong Zhang, Yaoying Chen, Huixi Li · 2025 · Annals of Medicine and Surgery
  44. Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database
    Ying Liu, Jintuo Zhou, Lihuan Song, Peiguang Niu · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  45. Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma
    Brooke C Braman, Martha A. Cady, Allison A. Merz-Herrala, Alon Witztum, Zora Arum, Scarlett Lin Gomez, Ramin A. Morshed, Javier E. Villanueva-Meyer, Nancy Ann Oberheim Bush, Susan Marina Chang et al. · 2026 · Neuro-Oncology
  46. Women and Contraceptives. Women’s Liberation?
    Danelia Cardona-Lozada · 2014 · Persona y Bioética
  47. Update on combined oral contraceptives: risk of venous thromboembolism. Drospirenone versus other progestins: CPC096 table 1
    C Martí Gil, A. Mulet Alberola, Marı́a Recuero, D. Barreira Hernández, Pilar Llopis Salvià, Dolores Barreda Hernández · 2012 · European Journal of Hospital Pharmacy
  48. Thrombose et contraception estroprogestative : mise au point du groupe de travail pluridisciplinaire CNGOF-FNCGM-GEHT-SFMV
    Nathalie Chabbert‐Buffet, B. Guigues, Nathalie Trillot, C. Biron, Pierre‐Emmanuel Morange, Gilles Pernod, Michèle Scheffler, S. Brugere, Bernard Hedon · 2013 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  49. The role of factor V Leiden and prothrombin G20210A mutations for clotting in Sudanese women under oral contraceptive use
    Osama Atiatalla Babiker Ahmed, Fathelrahman Mahdi Hassan, Mohammed Asad, Syed Mohammed Basheeruddin Asdaq, Abdulkhaliq Jassem Alsalman, Mohammad Al Mohaini, Abdulhakeem S. Alamri, Walaa Fahad Alsanie, Majid Alhomrani, Maitham Abdullah Al Hawaj et al. · 2021 · Journal of King Saud University - Science
  50. Evaluation the effect of oral contraceptive pills on coagulation profile in Sudanese women in Shendi -Sudan
    Omkalthoum Osman Abudegin, Layaly Ibrahim Elsigar, Mohammed Osman Ali, Eman Mohammed Khalifa · 2022 · World Journal of Biology Pharmacy and Health Sciences
  51. Challenges in Family Planning and Pregnancy for Women with Rheumatic Diseases
    Caroline H. Siegel, Lisa R. Sammaritano · 2023 · touchREVIEWS in RMD
  52. Study of Radioclinical and Risk Factors of Cerebral Venous Thrombosis: A Retrospective Analysis of Patients Presenting to a Tertiary Hospital in Mogadishu, Somalia
    Bakar Ali Adam, Ahmed Adam Osman, Mohamed Sheikh Hassan, Nor Osman Sidow, Mohamed Farah Osman Hidig, Abdulkadir Ahmed Mohamed, Abdiwahid Ahmed Ibrahim, Said Mohamed, Yahye Garad Mohamed, Said Abdirahman Ahmed et al. · 2025 · International Journal of General Medicine
  53. Foie et contraception orale
    Ariane Mallat · 2010 · Springer eBooks
  54. Hormonal contraception at patients of risk groups (а review)
    Елена Николаевна Кравченко, Анна Владимировна Мордык, Пузырева Лариса Владимировна, Валеева Галина Александровна · 2016 · Russian Journal of Human Reproduction
  55. Facteurs de risque de maladie veineuse thromboembolique chez les jeunes femmes en contexte hormonal
    Cécile Tromeur, Raphaël Le Mao, P. Jégo, Dominique El Kouri, Yves Gruel, Brigitte Pan‐Petesch, Laurent Bertoletti, Pierre‐Emmanuel Morange, É. Lemoigne, N. Paleiron et al. · 2018 · Revue des Maladies Respiratoires
  56. Risk factors venous and arterial thrombosis in young women out of pregnancy
    Natalia K. Vereina, Tatiana V. Movchan, В. С. Чулков · 2020 · Aterotromboz = Atherothrombosis
  57. Evaluating post-operative venous thromboembolism risk in urology patients using a validated risk assessment model
    Winston Padayachee, Mohamed Haffejee, Marietha Nel · 2021 · African Journal of Urology
  58. Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database
    Jami Wang, Mollie F. Qian, Michael Jeng, Joyce M. C. Teng · 2023 · Clinical Drug Investigation
  59. Renal Vein Thrombosis Occurring in Association with Oral Contraceptives: A Case Report
    Takuya Miyahara, Yoshifumi Nishino, Masahiko Ozaki, Masanori Ogiwara · 2023 · Annals of Vascular Diseases
  60. Surrogate Indexes of Insulin Resistance Are Affected by Sex and Gender and by the Combination of Smoking and Oral Contraceptives
    Giancarlo Tonolo, Andrea Montella, Mariangela Valentina Puci, Giovanni Sotgiu, Narcisa Muresu, Sara Cherchi, Mario Palermo, Giuseppe Seghieri, Flavia Franconi, Ilaria Campesi · 2024 · Diabetology
  61. Mujeres y anticonceptivos, ¿liberación femenina?
    Danelia Cardona-Lozada · 2014 · Intellectum (Universidad de La Sabana)
  62. Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel?
    Maria Inês da Rosa, Kristian Madeira, Lídia Rosi Medeiros · 2013 · The European Journal of Contraception & Reproductive Health Care
  63. Sex Hormones and Appetite in Women: A Focus on Bulimia Nervosa
    Sabine Naessén, Angelica Lindén Hirschberg · 2011 · Springer eBooks
  64. Superior Mesenteric Vein Thrombosis Associated with Hormonal Contraceptive Use
    Nobuatsu KOYAMA · 2016 · Case Reports in Gastroenterology
  65. Acne and acneiform eruptions
    Joanna M. Burch, John L. Aeling · 2011 · Elsevier eBooks
  66. Menopause and Cardiovascular Risk
    Angela H.E.M. Maas, C. Noel Bairey Merz · 2017 · Springer eBooks
  67. Combined oral contraception: is there a resource for increased use?
    Irina V. Kuznetsova, L. V. Evsyukova, Victor A. Konovalov · 2018 · Meditsinskiy sovet = Medical Council
  68. The Contraceptive Vaginal Ring
    Rachel S. Mandelbaum, Donna Shoupe · 2020 · Springer eBooks
  69. Antiandrogens and androgen inhibitors
    Marty E. Sawaya, Najwa Somani · 2013 · Elsevier eBooks
  70. Hormone-dependent gynaecological disorders and contraceptive modalities in women with a history of venous thromboembolic event: The THROMBOGYN study
    Victoria Mottais-Cosnefroy, Mathilde Pécourt, Alexandra Yannoutsos, Audrey Fels, Hélène Beaussier, S. Alran, Pascal Priollet, Justine Hugon‐Rodin · 2022 · JMV-Journal de Médecine Vasculaire
  71. Management of the Pregnant Woman with Congenital Heart Disease
    Ashley Park, Kristina Barbera, Carl H. Rose, Rachel Steury, Tacy E. Downing, Seiji Ito, Anitha S. John · 2023 · Springer eBooks
  72. Kontrazeption bei Jugendlichen
    Erich Möstl, Barbara B. Maier · 2011 · Monatsschrift Kinderheilkunde
  73. Facteurs de risque et scores de la maladie thromboembolique veineuse
    Carole Émile · 2012 · Option/Bio
  74. La píldora anticonceptiva a debate
    C. González-Hernando, M. Souza-de Almeida, Pedro Martín-Villamor, María José Cao Torija, María José Castro · 2013 · Enfermería Universitaria
  75. Hormonal Contraception and Sexuality
    Santiago Palacios, Mariella Lilue · 2018 · Current Sexual Health Reports
  76. Rheumatic Heart Disease in Pregnancy
    Ana Olga Mocumbi, Andrea Beaton, Priya Soma‐Pillay, Scott Dougherty, Karen S Sliwa · 2020 · Elsevier eBooks
  77. ADENDO: ACTUALIZACIÓN 27/06/2020. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud: Recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS. SEGUNDA EDICIÓN.
    Carlos Humberto Saavedra Trujillo · 2020 · Infectio
  78. Progestin‐Only Oral Contraceptive Pills
    Regina-Maria Renner, Jeffrey T. Jensen · 2011 · Contraception
  79. Reply to letter to the editor: “The INAS-OC study”
    Jürgen Dinger · 2014 · Contraception
  80. Kontrazeption & Thrombophilie - Eine Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e. V. und des Berufsverbands für Frauenärzte (BVF) e.V.
    T. Rabe, Beate Luxembourg, Michael Z. Ludwig, Juergen C Dinger, Rupert Martin Bauersachs, H. Rott, Mueck Ao, Christian Albring · 2012 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  81. Reply
    Samuel Shapiro, Juergen C Dinger · 2010 · Journal of Family Planning and Reproductive Health Care
  82. Addressing the unique challenges in studies of long‐term medication use and dementia risk
    Alexandra K. Lee, Sei J. Lee, Sascha Dublin · 2023 · Journal of the American Geriatrics Society
  83. Arterial thrombosis in users of contemporary hormonal contraception
    Therese Johansson · 2025 · BMJ
  84. Hormonal Contraception and Risk of Cardiometabolic Disease in Women with HIV
    Jamison Norwood, Cathy A. Jenkins, Manasa Bhatta, Megan M. Turner, Aihua Bian, Jeffrey Nelson, Imani Ransby, Dana Hughes, John Robert Koethe, Timothy R. Sterling et al. · 2024 · Journal of Women s Health
  85. Family Planning
    Anna Maria Paoletti, Gian Benedetto Melis, Bruno Piras, Monica Pilloni, Pierina Zedda, Maria Francesca Marotto, Valerio Vallerino, Anna Melis, Valeria Taccori, Virginia Melis et al. · 2024 · Obstetrics and gynecology.
  86. Increased risk of thromboembolism in patients with anorexia nervosa: a Danish nationwide registry-based study
    Jeanie Meincke Egedal, Pia Veldt Larsen, Jesper Hallas, Jan Magnus Sjögren, Else‐Marie Bladbjerg, René Klinkby Støving · 2025 · BMC Medicine
  87. Contraceptive effectiveness and safety of ormeloxifene: a systematic review
    Tesfaye H. Tufa, Muhammad Idrees, Goodness Ogeyi Odey, Asantesana Kamuyango, Nancy Kidula, Mojisola Oluwaseun Alere, Komal Preet Allagh, Rita Kabra, Julie G Thorne, James Njogu Kiarie · 2026 · BMJ Sexual & Reproductive Health
  88. Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis
    Dorothea M. Wunder, Gabriele S. Merki‐Feld · 2021 · Gynäkologische Endokrinologie
  89. The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
    Maria Abbattista, Addolorata Truma, Ida Martinelli, Francesca Gianniello, Serena M. Passamonti, Marco Capecchi, Andrea Artoni, Flora Peyvandi, Paolo Bucciarelli · 2025 · Journal of Thrombosis and Haemostasis
  90. The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives
    Jesper Strandberg, Jette Nybo, Inger Lise Gade, Søren Risom Kristensen · 2025 · Research and Practice in Thrombosis and Haemostasis
  91. Increased contact system activity three months after starting combined oral contraceptives
    Jesper Strandberg, Jette Nybo, Inger Lise Gade, Yaseelan Palarasah, Else‐Marie Bladbjerg, Søren Risom Kristensen · 2025 · Thrombosis Research
  92. Different Methods and Routes of Administration of Hormonal Contraception
    Martin Hans Birkhaeuser · 2026 · Reproductive medicine for clinicians
  93. Association of Biochemical Parameters With Hormonal Contraceptives Among Women Attending the Dschang Regional Annex Hospital, Cameroon: A Cross-Sectional Study
    Elvire Damaris Kwapnang Nzounkeu, Jaurès A. K. Noumedem, Jean-de-Dieu Tamokou · 2026 · Cureus
  94. Anticonceptivos orales y tromboembolismo venoso: la controversia de los progestágenos
    Rita Pizzi · 2014 · Revista de Obstetricia y Ginecología de Venezuela
  95. Pulmonary Embolism Secondary to Inappropriate use of Oral Contraceptive Therapy
    Scarlos Calderon Ospina · 2015 · Journal of Pharmacovigilance
  96. Can a meta-analysis that included articles with high heterogeneity appropriately evaluate the risk of venous thromboembolism in users of combined hormonal contraceptives containing drospirenone or desogestrel? A reply to Rosaet al.
    Francisca Martínez, Kepa Latorre, Isabel Cristina Ramírez, Ezequiel Pérez-Campos, Iñaki Lete · 2013 · The European Journal of Contraception & Reproductive Health Care
  97. Evidencias en anticoncepción
    Mariona Nadal Llover, Montse Cols Jiménez · 2014 · FMC - Formación Médica Continuada en Atención Primaria
  98. Oral contraceptives and venous thromboembolism: identifying the safest option
    Olívia Wu · 2009 · Expert Review of Cardiovascular Therapy
  99. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women
    Jessica L. Castilho, Cathy A. Jenkins, Bryan E. Shepherd, Sally S. Bebawy, Megan M. Turner, Timothy R. Sterling, Vlada V. Melekhin · 2015 · Journal of Women s Health
  100. Hormonal contraception and risk of venous thromboembolism: National follow-up study
    JAMES A. STOCKMAN · 2011 · Yearbook of Pediatrics